Adrenal Tumors in Patients with Pancreatic Neuroendocrine Tumors Abstract #1016

Introduction: The coexistence of adrenal tumors (AT) in patients with pancreatic neuroendocrine tumors (PNETs) has not been extensively studied.
Aim(s): To investigate prevalence and clinical significance in these patients.
Materials and methods: We retrospectively studied 75 patients with PNETs treated at our department between 2004 and 2012. pNETs were classified as proposed by ENETS. The nature of AT was evaluated pathohistologically when possible, or by CT/MRI characteristics indicative for benign/malignant lesion. AT functionality was assessed in all patients. Statistical analysis was performed by SPSS software.
Conference: 11th Annual ENETS Conference (2014)
Category: ...none of the below
Presenting Author: Bojana Popovic
Keywords: PNET, adrenal, tumor

To read results and conclusion, please login ...

Further abstracts you may be interested in

#103 From hormone dependent solid breast carcinoma to primary neuroendocrine carcinoma: a case report
Introduction: Primary neuroendocrine carcinoma of the breast is an extremely rare tumor with incidence of 0.27-0.5%.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Djuro P Macut
Authors: Macut D, Kecman G, Bogavac T, Popovic B, ...
#117 Synchronous appendiceal neuroendocrine carcinoma and mucinous cystadenocarcinoma: a case report
Introduction: Appendiceal tumors with histological features of both carcinoids and adenocarcinomas are very rare. Carcinomas of the appendix are usually mucinous adenocarcinomas with a tendency to produce peritoneal pseudomyxoma and without metastatic spread until late in the disease course. Carcinoid tumors of the appendix are a common incidental finding.
Conference: 7th Annual ENETS Conference (2010)
Category: Clinical
Presenting Author: Dr Sanja Ognjanovic
#522 Effects of Transarterial Chemoembolization of Liver Metastases from Neuroendocrine Tumors on Clinical Outcome
Introduction: Trans-catheter arterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases from neuroendocrine tumors (NET) which provides control of clinical symptoms and tumor growth.
Conference: 9th Annual ENETS Conference (2012)
Category: Clinical
Presenting Author: Dr Sanja Ognjanovic
#785 Efficacy of Transarterial Chemoembolization of Liver Metastases from Neuroendocrine Tumors
Introduction: Most patients with neuroendocrine tumors present with liver involvement at the time of diagnosis. Transarterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases which is effective in the control of symptoms and tumor growth.
Conference: 10th Annual ENETS Conference (2013)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: dr Sanja Ognjanovic
#1018 Transarterial Chemoembolization for Unresectable Liver Neuroendocrine Metastases
Introduction: Most patients with neuroendocrine tumors (NETs) present with liver involvement at the time of diagnosis. Trans-catheter arterial chemoembolization (TACE) is a method of treatment of non-resectable liver metastases.
Conference: 11th Annual ENETS Conference (2014)
Category: PRRT-Ablative therapies-Endoscopic treatment
Presenting Author: Sanja Ognjanovic
Close
Notice

Dear conference participant,

Thank you for participating in the ENETS Virtual Conference 2020!

You now have the opportunity to view the webcasts, abstracts and e-posters via My ENETS. Don't miss out any of the exciting talks and take your time to view the clinical and basic science abstract sessions.

If you require a certificate of attendance, please log into My ENETS and select “Annual Conferences” from the side menu, then click on “My registrations” and select your registration for 2020. Please choose "Certificate o.A." to receive your certificate of attendance.

A note on CME accreditation:

ENETS has been liaising with UEMS regarding CME accreditation for the virtual conference. At present, we do not have a definitive answer. We will keep you updated.

 

Wishing you all the best,

The entire ENETS team